Drug Diversion and COVID-19
Published date: March 3, 2021
Drug diversion didn’t disappear when COVID-19 patients arrived at your hospital in 2020. Many changes associated with managing the COVID-19 pandemic in hospitals may in fact be creating new opportunities for drug diversion that could be difficult to detect if you don’t know what you are looking for.
This article will outline some of the COVID-19 changes and introduce a new model, the Drug Diversion Triad, to demonstrate the impact of COVID-19 on drug diversion in US hospitals.
Read the full article here
Citation: Copyright 2021 Compliance Today, a publication of the Health Care Compliance Association (HCCA)